Results 111 to 120 of about 30,153 (204)

Adherence to Aromatase Inhibitor Therapy in Breast Cancer: Insights From a Multicenter Italian Study. [PDF]

Breast J
Fabbri MA, Fulvi A, Vergati M, D'Auria G, Vici P, Filomeno L, Arcuri T, Palazzo A, Nelli F, Fiore C, Portarena I, Falbo PT, Rossi R, Alesini D, Sini V, Pace R, Frittelli P, Corsi DC, Palombi L, Pisegna S, Botticelli A, Scagnoli S, Pistillucci G, Giordani E, La Cesa A.   +24 more
europepmc   +1 more source

Corrigendum to "Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer" [The Breast 86 (2026) 104744]. [PDF]

Breast
Brufsky A, Layman RM, Liu X, Li B, McRoy L, Cohen AB, Estevez M, Cottu P, Curigliano G, Rugo HS.   +9 more
europepmc   +1 more source

Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer. [PDF]

Cancers (Basel)
Cvetanović AS, Jankovic KB, Stojković AS, Živković ND, Kostić MS, Popović LS.   +5 more
europepmc   +1 more source

Aromatase Inhibitor-Related Alveolar Hemorrhage or ANCA-Associated Vasculitis? [PDF]

Eur J Breast Health
Büyükavcı R.
europepmc   +1 more source

Improve product quantity of aromatase inhibitor from Nicotiana tabaccum by metabolic engineering techique

, 2010
OBJECTIVES The objectives of this project are: To increase amount of aromatase inhibitor from Nicotiana tabacum To block sub-nicotine pathway in order to increase the amount of ...
Jimat, Dzun Noraini, Amid, Azura
core  

Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2- Metastatic Breast Cancer. [PDF]

Cancer Med
Brufsky AM, Sandin R, Stergiopoulos S, Chen C, Karanth S, Li B, Esterberg E, Makari D, Candrilli SD, Goyal RK, Rugo HS.   +10 more
europepmc   +1 more source

Early adapted physical activity to prevent and manage aromatase inhibitor-induced musculoskeletal pain in breast cancer: protocol for a hybrid effectiveness-implementation randomised controlled trial (APIS). [PDF]

BMJ Open Sport Exerc Med
Piazzon N, Verot E, Gérard A, Baudot A, Carrouel F, Cortet M.   +5 more
europepmc   +1 more source

Aromatase Inhibitors

Oncology Times, 2008
openaire   +3 more sources

Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Breast Cancer. [PDF]

Cancer Med
Fleege NMG, Miller EA, Kidwell KM, Zacharias ZR, Houtman J, Scheu K, Kemmer K, Boehnke KF, Henry NL.   +8 more
europepmc   +1 more source

Efficacy of denosumab versus alendronate for aromatase inhibitor-associated osteoporosis in postmenopausal breast cancer patients: a retrospective analysis. [PDF]

BMC Musculoskelet Disord
Zhang Y, Cui W, Hou L.
europepmc   +1 more source